Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...

(Reuters) -Cardiac diagnostic software maker Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in ...

UnitedHealth Group announced an executive swap amid a turbulent era for the company that included its CEO being killed and ...

Bristol Myers partners with Bain Capital to launch a new autoimmune-focused biotech, out-licensing five key immunology assets ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives, Dan Lynch, and ...

Lincoln National's Q2 beat highlights cost cuts, a Bain Capital stake, and Group Protection growth. Read more for insights on ...

On July 11, Rhode Island Gov. Dan McKee reportedly met at the Amica Mutual Pavilion to discuss the possibility of relocating ...

US pharma major Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company ...

The biopharma spinoff will advance the development of its five investigational therapies designed to treat autoimmune disease.